The use of sympathomimetic amines for the treatment of severe constipation refractory to conventional therapy--case report.

Clin Exp Obstet Gynecol

The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ, USA.

Published: September 2013

Purpose: Sympathetic nervous system hypofunction has been found to be associated with motility disorders of the bowel, including gastroparesis, pseudointestinal obstruction, and esophageal motility disorders. These disorders respond to sympathomimetic amine therapy. The purpose of this study was to see if this therapy could be effective in treating pathological constipation.

Materials And Methods: Dextroamphetamine sulfate 15 mg extended release capsules was prescribed to an 18-year-old young woman who had severe constipation with a bowel movement every two to three weeks and sometimes every five to six weeks who did not respond to standard therapy and where no definite etiology was determined.

Results: Two hours after her first dosage of the sympathomimetic amine, she had a bowel movement and has had regular bowel movements ever since.

Conclusions: Sympathomimetic amine therapy seems to help severe constipation refractory to standard therapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

severe constipation
12
sympathomimetic amine
12
constipation refractory
8
motility disorders
8
amine therapy
8
bowel movement
8
standard therapy
8
therapy
5
sympathomimetic
4
sympathomimetic amines
4

Similar Publications

Randomized controlled trial protocol to analyze the effects of rice with different contents of resistant starch on chronic constipation.

Sci Rep

December 2024

Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, West China Hospital, and West China School of Nursing, Sichuan University, PO Box No.37, Guo Xue Street, Chengdu, 610041, Sichuan, PR China.

The trend of the aging population worldwide is becoming increasingly severe. As people age, constipation becomes increasingly common in older adults, causing varying degrees of physical and psychological harm to them. Dietary intervention is a common nonpharmacological therapy.

View Article and Find Full Text PDF

Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis.

Eur Neuropsychopharmacol

December 2024

SCIENCES Lab, Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; Department of Mental Health, The Ottawa Hospital, Ottawa, Canada; Ottawa Hospital Research Institute: Clinical Epidemiology Program, University of Ottawa, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada. Electronic address:

The United States Food and Drug Administration approved xanomeline-trospium combination for schizophrenia on September-26-2024. We conducted a PRISMA 2020-compliant systematic review with random-effects meta-analysis on the efficacy and safety of xanomeline-trospium in randomized controlled trials in patients with schizophrenia (MEDLINE, EMBASE, Cochrane, PsycINFO, October-01-2024). Co-primary outcomes were Positive And Negative Syndrome Scale (PANSS) total score (standardized mean difference=SMD), and all-cause discontinuation (risk ratio=RR).

View Article and Find Full Text PDF

Background And Aim: Functional gastrointestinal disorders such as chronic constipation (CC) and chronic diarrhea (CD) impose a significant burden on global healthcare resources. Food insecurity, a crucial social determinant of health, remains unclearly associated with CC and CD. We aim to explore the association between food insecurity and CC and CD, and its impact on all-cause mortality among participants with abnormal bowel health.

View Article and Find Full Text PDF

A prospective, historical-controlled evaluation of oliceridine for moderate or severe pain in patients with acute burn injuries (RELIEVE).

Burns

November 2024

Department of Pharmacy, Regional One Health, Firefighter's Burn Center, Regional One Health, 877 Jefferson Avenue, Memphis, TN 38103, USA.

Oliceridine, a biased, selective opioid agonist, has shown a 3-fold preferential activation of the G-protein (i.e., analgesia) over β-arrestin pathway.

View Article and Find Full Text PDF

Background: Acne is a common inflammatory dermatosis. Although gender-related differences in prevalence and age of onset have been documented. Other gender-related characteristics of acne have not been well elucidated yet.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!